Steven Cohen’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.32M Buy
491,918
+118,819
+32% +$1.28M 0.01% 1499
2026
Q1
$3.16M Sell
373,099
-14,700
-4% -$161K ﹤0.01% 2007
2025
Q4
$4.38M Buy
387,799
+306,799
+379% +$3.8M ﹤0.01% 1938
2025
Q3
$1.22M Buy
+81,000
New +$1.18M ﹤0.01% 1625
2025
Q1
Sell
-922,965
Closed -$34.5M 2053
2024
Q4
$34.5M Sell
922,965
-577,319
-38% -$26.9M 0.08% 307
2024
Q3
$75M Buy
1,500,284
+1,322,922
+746% +$51.5M 0.19% 126
2024
Q2
$6.16M Sell
177,362
-732,238
-81% -$29M 0.02% 785
2024
Q1
$49.7M Sell
909,600
-1,573,967
-63% -$77.9M 0.12% 202
2023
Q4
$106M Buy
2,483,567
+1,458,072
+142% +$45.3M 0.26% 83
2023
Q3
$26.7M Sell
1,025,495
-145,303
-12% -$3.02M 0.08% 323
2023
Q2
$28M Sell
1,170,798
-1,551,935
-57% -$26.7M 0.08% 296
2023
Q1
$37.2M Buy
2,722,733
+1,491,324
+121% +$23.7M 0.12% 217
2022
Q4
$17.1M Buy
1,231,409
+842,768
+217% +$11.9M 0.06% 377
2022
Q3
$2.39M Buy
+388,641
New +$2.82M 0.01% 889

Other funds holding BHVN

Steven Cohen's BHVN Position: Q2 2026 in Review

Steven Cohen increased its Biohaven (BHVN) stake by 32% in Q2 2026, buying an estimated $1.28M and bringing the position to 491,918 shares worth $7.32M. The position accounts for 0.01% of the portfolio, ranked #1499.

Steven Cohen first reported a position in BHVN in Q3 2022 and has held it in 14 quarters since. The position peaked at $106M in Q4 2023. 291 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Steven Cohen held 491,918 shares of Biohaven worth $7.32M as of Q2 2026.
  • Steven Cohen bought 118,819 Biohaven shares in Q2 2026, an estimated $1.28M.
  • Biohaven made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1499 holding.
  • Steven Cohen first reported a position in Biohaven in Q3 2022 and has held it in 14 quarters since.
  • Steven Cohen's Biohaven position peaked at $106M in Q4 2023.
  • 291 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.